|
Volumn 17, Issue 3, 2000, Pages 3-12
|
Chronic obstructive pulmonary disease.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
BRONCHODILATING AGENT;
GLUCOCORTICOID;
ADULT;
AGED;
ARTICLE;
BRONCHITIS;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLASSIFICATION;
DENTAL CARE;
FEMALE;
FORCED EXPIRATORY VOLUME;
HUMAN;
LUNG DIFFUSION CAPACITY;
LUNG EMPHYSEMA;
MALE;
MIDDLE AGED;
OXYGEN THERAPY;
PATHOLOGY;
PATHOPHYSIOLOGY;
PEAK EXPIRATORY FLOW;
PHYSIOLOGY;
PREVALENCE;
RESPIRATORY FAILURE;
RISK FACTOR;
SMOKING CESSATION;
UNITED KINGDOM;
VITAL CAPACITY;
ADRENERGIC BETA-AGONISTS;
ADULT;
AGED;
BRONCHITIS;
BRONCHODILATOR AGENTS;
DENTAL CARE FOR CHRONICALLY ILL;
FEMALE;
FORCED EXPIRATORY VOLUME;
GLUCOCORTICOIDS;
GREAT BRITAIN;
HUMANS;
LUNG DISEASES, OBSTRUCTIVE;
MALE;
MIDDLE AGED;
OXYGEN INHALATION THERAPY;
PEAK EXPIRATORY FLOW RATE;
PREVALENCE;
PULMONARY DIFFUSING CAPACITY;
PULMONARY EMPHYSEMA;
RESPIRATORY INSUFFICIENCY;
RISK FACTORS;
SMOKING CESSATION;
VITAL CAPACITY;
|
EID: 0034232572
PISSN: 00491160
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|